Biological features of primary APL blasts: their relevance to the understanding of granulopoiesis, leukemogenesis and patient management.
In recent years, discovery of the in vitro and in vivo differentiation of APL blasts by all-trans retinoic acid (ATRA) has modified the therapeutic approach of APL and lead to important advances in understanding the biology of APL. Since it became apparent that differentiation therapy of APL with ATRA was indeed a true model of targetted therapy, evidencing the molecular targets of retinoic acid efficacy became crucial. These molecular targets are closely related to the biological features of APL cells, some of which are well-known and have contributed to the morphological and cytogenetic definition of the leukemia, others have just been defined or re-discovered in the light of a better understanding of molecular controls of cell growth and differentiation. The aims of characterizing the biological features of APL cells should allow a better management of APL therapy and the identification of potential markers for differentiation therapies in other leukemias or solid tumors.
Cassinat
B
B
Hopital Saint-Louis, Paris, Institute of Hematology, INSERM E 00-03 France.
Chomienne
C
C
D014408:Biomarkers, Tumor; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D019468:Disease Management; D006098:Granulocytes / Q000166:cytology*; D006410:Hematopoiesis; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism* / Q000473:pathology*; D015398:Signal Transduction / Q000187:drug effects; D014212:Tretinoin / Q000378:metabolism / Q000627:therapeutic use
D014408:Biomarkers, Tumor; D014212:Tretinoin